Skip to content

Medical-device intelligence

JXM: Enzyme Immunoassay, Benzodiazepine

FDA product code JXM: Enzyme Immunoassay, Benzodiazepine. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
JXM
FDA device name
Enzyme Immunoassay, Benzodiazepine
Device class
2
Regulation number
862.3170
Medical specialty
Clinical Toxicology
Review panel
TX

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore clinical toxicology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

90 clearance records and 81 recall records in the covered releases, across 43 source company names and 1 product codes. Dated history runs from Apr 26, 1979 to Dec 11, 2024.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
JXM · Enzyme Immunoassay, Benzodiazepine9081

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

171 matching records
Device / recordCompany in FDA recordSourceSource date
ADX TM BENZODIAZEPINESK890691 · JXMAbbott Laboratories510(k)Aug 25, 1989FDA decision date
ABUSCREEN FP BENZODIAZEPHINE REAGENTK891697 · JXMRoche Diagnostic Systems, Inc.510(k)Mar 31, 1989FDA decision date
DOUBLE ANTIBODY SERUM BENZODIAZEPINESK890001 · JXMDiagnostic Products Corp.510(k)Jan 24, 1989FDA decision date
TDX BENZODIAZEPINES SERUMK883730 · JXMAbbott Laboratories510(k)Nov 29, 1988FDA decision date
DOUBLE ANTIBODY BENZODIAZPINES #KBZD1, KBZD5K883459 · JXMDiagnostic Products Corp.510(k)Sep 9, 1988FDA decision date
REVISIED LABELING FOR ADX BENZODIAZEPINESK880014 · JXMAbbott Laboratories510(k)Feb 11, 1988FDA decision date
REVISED LABELING FOR SYVA BENZODIAZEPINE ASSAYSK874376 · JXMSyva Co.510(k)Nov 23, 1987FDA decision date
REVISED LABELING FOR TDX BENZODIAZEPINESK874489 · JXMAbbott Laboratories510(k)Nov 23, 1987FDA decision date
REVISED LABELING FOR BENZODIAZEPINE TEST KITK874265 · JXMRoche Diagnostic Systems, Inc.510(k)Nov 13, 1987FDA decision date
ACA URINE BENZODIAZEPINES (UBENZ) SCREEN METHODK873538 · JXME.I. Dupont DE Nemours & Co., Inc.510(k)Oct 2, 1987FDA decision date
ABUSCREEN RADIOIMMUNOASSAY FOR BENZODIAZEPINESK870994 · JXMRoche Diagnostic Systems, Inc.510(k)Mar 24, 1987FDA decision date
BENZODIAZEPINE ENZYME IMMUNOASSAY KITK863877 · JXMGeneral Diagnostics510(k)Mar 12, 1987FDA decision date
TDX BENZODIAZEPINESK862250 · JXMAbbott Laboratories510(k)Jul 11, 1986FDA decision date
EMIT 700 BENZODIAZEPINE ASSAYK851568 · JXMSyva Co.510(k)May 10, 1985FDA decision date
EMIT D.A.U. BENZODIAZEPINE ASSAYK842815 · JXMSyva Co.510(k)Sep 26, 1984FDA decision date
ACA BENZODIAZEPINES SCREEN TEST PKK842387 · JXME.I. Dupont DE Nemours & Co., Inc.510(k)Aug 15, 1984FDA decision date
EMIT ST SERUM BENZODIAZEPINE ASSAYK840236 · JXMSyva Co.510(k)Mar 19, 1984FDA decision date
MODIF. OF EMIT URINE BENZODIAZEPINEK833578 · JXMSyva Co.510(k)Jan 26, 1984FDA decision date
EMIT-ST SERUM BENZODIAZEPINE ASSAYK810463 · JXMSyva Co.510(k)Mar 6, 1981FDA decision date
EMIT-STM BENZODIAZEPINE ASSAYK802616 · JXMSyva Co.510(k)Oct 31, 1980FDA decision date
EMIT-TOX SERUM BENZODIAZEPINE ASSAYK790736 · JXMSyva Co.510(k)Apr 26, 1979FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗